• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDKL5 缺乏症严重程度 caregiver报告量表的开发、内容和反应过程验证。

The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorder.

机构信息

University of Colorado School of Medicine Department of Pediatrics, Section of Pediatric Hospital Medicine, 13123 East 16th Avenue, Box 302, Aurora, CO, United States; Children's Hospital Colorado Precision Medicine Institute, 13123 East 16th Avenue, Box 155, Aurora, CO 80045 United States.

University of Colorado School of Medicine Department of Pediatrics, Section of Neurology, 13123 East 16th Avenue, Box 155, Aurora, CO 80045, United States.

出版信息

Epilepsy Res. 2023 Nov;197:107231. doi: 10.1016/j.eplepsyres.2023.107231. Epub 2023 Sep 20.

DOI:10.1016/j.eplepsyres.2023.107231
PMID:37751639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10760432/
Abstract

BACKGROUND

CDKL5 Deficiency Disorder (CDD) is a severe X-linked developmental and epileptic encephalopathy. Existing developmental outcome measures have floor effects and cannot capture incremental changes in symptoms. We modified the caregiver portion of a CDD clinical severity assessment (CCSA) and assessed content and response-process validity.

METHODS

We conducted cognitive interviews with 15 parent caregivers of 1-39-year-old children with CDD. Caregivers discussed their understanding and concerns regarding appropriateness of both questions and answer options. Item wording and questionnaire structure were adjusted iteratively to ensure questions were understood as intended.

RESULTS

The CCSA was refined during three rounds of cognitive interviews into two measures: (1) the CDD Developmental Questionnaire - Caregiver (CDQ-Caregiver) focused on developmental skills, and (2) the CDD Clinical Severity Assessment - Caregiver (CCSA-Caregiver) focused on symptom severity. Branching logic was used to ensure questions were age and skill appropriate. Initial pilot data (n = 11) suggested no floor effects.

CONCLUSIONS

This study modified the caregiver portion of the initial CCSA and provided evidence for its content and response process validity.

摘要

背景

CDKL5 缺乏症(CDD)是一种严重的 X 连锁发育性和癫痫性脑病。现有的发育结果测量方法存在下限效应,无法捕捉症状的增量变化。我们修改了 CDD 临床严重程度评估(CCSA)的照顾者部分,并评估了其内容和反应过程的有效性。

方法

我们对 15 名 1-39 岁患有 CDD 的儿童的照顾者进行了认知访谈。照顾者讨论了他们对问题和答案选项的适当性的理解和关注。通过迭代调整问题措辞和问卷结构,以确保问题得到了预期的理解。

结果

在三轮认知访谈中,CCSA 被细化为两个衡量标准:(1)关注发育技能的 CDD 发育问卷-照顾者(CDQ-Caregiver),(2)关注症状严重程度的 CDD 临床严重程度评估-照顾者(CCSA-Caregiver)。采用分支逻辑来确保问题适合年龄和技能。初步试点数据(n=11)表明不存在下限效应。

结论

本研究对初始 CCSA 的照顾者部分进行了修改,并提供了其内容和反应过程有效性的证据。

相似文献

1
The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorder.CDKL5 缺乏症严重程度 caregiver报告量表的开发、内容和反应过程验证。
Epilepsy Res. 2023 Nov;197:107231. doi: 10.1016/j.eplepsyres.2023.107231. Epub 2023 Sep 20.
2
Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).CDKL5 缺乏症手功能量表(CDD-Hand)的初步验证和可靠性。
J Child Neurol. 2022 May;37(6):541-547. doi: 10.1177/08830738221091044. Epub 2022 Apr 14.
3
Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study.照顾者观察到的 CDKL5 缺乏症患者的沟通:一项描述性定性研究。
Am J Med Genet A. 2024 Jul;194(7):e63570. doi: 10.1002/ajmg.a.63570. Epub 2024 Feb 29.
4
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.用于评估 CDKL5 缺乏症严重程度的临床报告项目的内容验证。
J Child Neurol. 2021 Oct;36(11):998-1006. doi: 10.1177/08830738211019576. Epub 2021 Aug 11.
5
Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric study.为患有CDKL5缺陷障碍的个体改编一项粗大运动技能测量方法:一项心理测量学研究。
Epilepsy Res. 2024 Feb;200:107287. doi: 10.1016/j.eplepsyres.2024.107287. Epub 2024 Jan 15.
6
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorder.CDKL5 缺乏症患者的临床医生和照顾者报告的临床严重程度评估的心理测量学评估。
Epilepsia. 2024 Oct;65(10):3064-3075. doi: 10.1111/epi.18094. Epub 2024 Aug 27.
7
A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.了解 CDKL5 缺乏症患者生活质量领域的框架。
Am J Med Genet A. 2019 Feb;179(2):249-256. doi: 10.1002/ajmg.a.61012. Epub 2018 Dec 18.
8
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.CDKL5 缺乏症:基因型、癫痫、皮质性视觉障碍与发育的关系。
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
9
Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.利用国际数据集探索 CDKL5 缺乏症的基因型-表型关系。
Clin Genet. 2021 Jan;99(1):157-165. doi: 10.1111/cge.13862. Epub 2020 Oct 20.
10
Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.老年杂合性 Cdkl5 突变小鼠表现出自发性癫痫痉挛。
Exp Neurol. 2020 Oct;332:113388. doi: 10.1016/j.expneurol.2020.113388. Epub 2020 Jun 22.

引用本文的文献

1
The long odyssey for the DEE-CDKL5 diagnosis: A call for action.DEE-CDKL5诊断的漫长征程:行动呼吁。
Epilepsia Open. 2024 Dec;9(6):2164-2172. doi: 10.1002/epi4.13031. Epub 2024 Sep 9.
2
Deletions in the CDKL5 5' untranslated region lead to CDKL5 deficiency disorder.CDKL5基因5'非翻译区的缺失会导致CDKL5缺乏症。
Am J Med Genet A. 2025 Jan;197(1):e63843. doi: 10.1002/ajmg.a.63843. Epub 2024 Aug 28.
3
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorder.CDKL5 缺乏症患者的临床医生和照顾者报告的临床严重程度评估的心理测量学评估。
Epilepsia. 2024 Oct;65(10):3064-3075. doi: 10.1111/epi.18094. Epub 2024 Aug 27.

本文引用的文献

1
CDKL5 deficiency disorder: clinical features, diagnosis, and management.CDKL5 缺乏症:临床特征、诊断与管理。
Lancet Neurol. 2022 Jun;21(6):563-576. doi: 10.1016/S1474-4422(22)00035-7. Epub 2022 Apr 25.
2
Rare diseases - rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies.罕见病——罕见结局:发育性和癫痫性脑病的沟通能力评估。
Epilepsy Behav. 2022 Mar;128:108586. doi: 10.1016/j.yebeh.2022.108586. Epub 2022 Feb 11.
3
Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.CDKL5 缺乏症相关脑性视觉障碍与发育成就相关。
J Child Neurol. 2021 Oct;36(11):974-980. doi: 10.1177/08830738211019284.
4
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.用于评估 CDKL5 缺乏症严重程度的临床报告项目的内容验证。
J Child Neurol. 2021 Oct;36(11):998-1006. doi: 10.1177/08830738211019576. Epub 2021 Aug 11.
5
Bringing Scientific Rigor to Survey Design in Health Care Research.将科学严谨性引入医疗保健研究中的调查设计。
Hosp Pediatr. 2019 Oct;9(10):743-748. doi: 10.1542/hpeds.2019-0101. Epub 2019 Sep 4.
6
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.CDKL5 缺乏症:基因型、癫痫、皮质性视觉障碍与发育的关系。
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
7
Severity Assessment in CDKL5 Deficiency Disorder.CDKL5 缺乏症的严重程度评估。
Pediatr Neurol. 2019 Aug;97:38-42. doi: 10.1016/j.pediatrneurol.2019.03.017. Epub 2019 Mar 27.
8
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
9
Guidelines for Reporting Survey-Based Research Submitted to Academic Medicine.提交给《学术医学》的基于调查研究的报告指南。
Acad Med. 2018 Mar;93(3):337-340. doi: 10.1097/ACM.0000000000002094.
10
The Survey Checklist (Manifesto).调查问卷清单(宣言)。
Acad Med. 2018 Mar;93(3):360-366. doi: 10.1097/ACM.0000000000002083.